| __timestamp | Agios Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 882000 |
| Thursday, January 1, 2015 | 141827000 | 1361000 |
| Friday, January 1, 2016 | 220163000 | 2058000 |
| Sunday, January 1, 2017 | 292681000 | 3554000 |
| Monday, January 1, 2018 | 1397000 | 5215000 |
| Tuesday, January 1, 2019 | 1317000 | 5504000 |
| Wednesday, January 1, 2020 | 2805000 | 5582000 |
| Friday, January 1, 2021 | 18777000 | 5281000 |
| Saturday, January 1, 2022 | 1704000 | 5385000 |
| Sunday, January 1, 2023 | 9504000 | 6481000 |
| Monday, January 1, 2024 | 4165000 |
Cracking the code
In the competitive world of biotechnology, cost efficiency is a critical factor for success. This analysis compares the cost of revenue efficiency between Corcept Therapeutics Incorporated and Agios Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, Corcept Therapeutics has demonstrated remarkable consistency, with its cost of revenue increasing by approximately 635%, from $882,000 to $6.48 million. In contrast, Agios Pharmaceuticals experienced a more volatile journey, with a peak in 2017, where costs soared to nearly $293 million, before stabilizing to around $9.5 million in 2023.
This comparison highlights Corcept's steady growth and cost management, while Agios's fluctuating costs reflect its dynamic strategic shifts. Investors and industry analysts can glean insights into each company's operational efficiency and strategic focus, providing a clearer picture of their financial health and potential for future growth.
Cost of Revenue Comparison: Eli Lilly and Company vs Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Novo Nordisk A/S and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Merck & Co., Inc. and Corcept Therapeutics Incorporated
Cost of Revenue Trends: Pfizer Inc. vs Agios Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Zoetis Inc. and Agios Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Takeda Pharmaceutical Company Limited and Corcept Therapeutics Incorporated
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Cost of Revenue Comparison: Biogen Inc. vs Corcept Therapeutics Incorporated
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and Corcept Therapeutics Incorporated
Analyzing Cost of Revenue: Perrigo Company plc and Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Agios Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.